The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
That seems a reasonable strategy har Chris . Personally if I haven't seen anything before resolution I like I am out...but could still keep an eye on progress.
B2..the only thing about that which would concern me... is if they go along with ygen stuff as the main thing ...it could be a case of sinking cash in...then you need more and more or risk losing what you have put in..
Of course if they start buying other stuff...and good stuff not just for the sake of buying ..then that would be good
Well at least if we win ..it could get interesting. The last few years have been very painful sitting in a loss
2 Jan 2024 - RNS -
Steve Gibson - Appointment of CFO
Commenting, James Wakefield, Non-Executive Chairman, said: "We are delighted to welcome Steve as our CFO. He has impressed us with his financial and operational expertise and was instrumental in the acquisition of Yourgene Health plc as well as delivering the strategic changes to the Company over the last two years. The Board looks forward to working with him as we continue to execute our growth strategy."
IMO that's JW saying SG is his financial man, and LR will have to budget his plans accordingly, else SG will advise JW of overspend.
That's the thing though CS what makes a good AIM ceo? It's one that, like you say, first and foremost knows how to play the AIM game and is able to attract investment. Most of the 'big wins' on AIM require a healthy smidge of fortune and what you want is a leader that is able to make the most of anything that goes their way and leverage the sentiment when it's with them.
I feel Lyn is likely to be able to do that and on the specific business front he's been given a second bite at the cherry with a company, sector and market that he knows inside out, which should also be useful when it comes to M&A.
I was planning to largely exit upon a positive dispute outcome but now I'm leaning towards keeping at least 50% and giving this new management team a chance to show what they can do, unless any spike is simply too good to resist.
Look you can see why ygen holders are disgruntled to say the least...and I would be too.
The issue is that we didn't have any better candidate from existing staff..and I really don't have confidence in ncyt to get any one from outside after salad man....i mean how wrong can they be...So he was the best choice of a very bad bunch
On the plus side he knows the products inside and out and prob has a plan already ...if he had had the money. He also knows how to play the aim game...and say things punters want to hear..and rns things.
He prob knows he has up to two months or so to convince people who are planning to leave on the resolution of the dispute either way. I suspect he will try to hit the ground running next week.
Personally I will see how he responds. I always said I would be out on dispute result...but will give him the chance to change my mind
If Lyn Rees was as useless and profligate as frustrated YG holders claim he is there is no chance he would have finagled his way to Novacyt CEO within a handful of months. James McCarthy may be a rubbish CEO but he's a sensible enough man, he waited til there was a suitable replacement to step aside and clearly both James McCarthy and Wakefield consider Lyn to be that individual.
And if profligacy is top of the list of accusations then it's great news that the former YG CFO isn't joining too - instead we have a safe pair of hands in Steve Gibson keeping Lyn in check this time around.
It is entirely feasible that LR thought he would have a cash injection from the sale of the Taiwan lab. The markets were in a downward spiral and the ability to raise without diluting to oblivion wasn't an option.
Regarding LR spaffing the NCYT treasure chest up the wall, forewarned is forearmed.
Don't think there will be any LTH's who won't have that at the top of their watch list .
What happened to OptimisticGuy? Did he get banned?
One would ask, who you would replace LR with? Rather than just attack his past? #PeopleChange
I like your optimism WBAFC.
But imagine you have a CEO who was lied in the past and destroyed shareholder value. Below are few videos just before he put yourgene to ground.
https://www.youtube.com/watch?v=ZgY1bMsfyTQ&ab_channel=InvestorMeetCompany see this video from 34:00 onwards
https://www.youtube.com/watch?v=u6U_By8AhWA&ab_channel=BruntwoodSciTech from 1 year ago
The above videos will tell you how good he is with marketing but outcome was zero and company went bankrupt.
Londonwatcher , if you got burnt from Yourgene then I completely sympathise with you and understand how you feel with LR . We are hoping LR has learnt from his experience and will make good business judgement now. He will have a lot of money to play with at Novacyt , hopefully £130M + after the DHSC case is clarified. I cannot imagine LR will make the same mistakes again and sink Novacyt. He will be rewarded exceptionally well , for each £1 rise he will get almost £1M . LR will never get a better opportunity anywhere like this in his life , and he probably knows this is his last big pay deal he will ever get . If he fails , I doubt anyone will ever employ him has a CEO. LR will be aiming the SP to be has high has possible £20+
LR is the captain of NCYT and is going to sink this company as well.
LW your reason for being here is what? Why bother?
Can you trust a CEO who lied in the past and hide the facts from shareholders? I won’t as someone who lied in the past can do the same in future. For me it’s a question of ethics.
His pet statement was that we are building a business and SP will rise on its own. And he drove the company to bankruptcy.
I don’t trust him as he has no business acumen. He will burn all ncyt money and will this company to bankruptcy as well.
Londonwatcher , maybe you got your fingers burnt with Yourgene and that's why you hate LR. What LR has now is lots of cash to play with. ! This share is a big buy I suggest
I have zero confidence in LR as he has been positioning yourgene in a big way and was burning cash at excessive rate which ultimately push the company into ground.
With LR leading NCYT except from good marketing / LinkedIn post don’t expect much happening.
My thinking is we have a strong BOD with now how that has the ability to develop Novacyt into a billion pound company. Once the DHSC case has been clarified , the £130M+ in cash would allow scope for 3- 4 good acquisitions and generate profit margins of more than £100M annually. The LTIP , even though set at £1.38 is low , it more or less guarantees them , the BOD , the maximum shares. All LR & board need to focus on is creating a strong business plan and capturing companies that are in trouble ( like Yourgene were ) and have the potential of strong revenue with the right direction. Joanne Mason 'JM' appears to be commercially tuned with knowing what diagnostic molecular companies are doing what and how well . I make that obervation merely by the fact I notice she is clicking onto so many different molecular diagnostic companies on LinkedIn which I didn't see from James McCarthy or David Allmond or James Wakefield. Graham Mullis is still very active on LinkedIn and always clicking onto companies and executive personal. The fact JM is seen to be looking at various companies demonstrates she is seen to be active unlike the others I mentioned.
Bird flu virus found in one-fifth of US milk samples, testing shows.
Early results from sampling study suggest bird flu could be widespread in America’s commercial supplies.
The PCR tests used to analyse the samples can detect both live and dead virus fragments, but cannot distinguish between the two.
“Additional testing is required to determine whether intact pathogen is still present and if it remains infectious, which would help inform a determination of whether there is any risk of illness associated with consuming the product,” the FDA said.
https://www.telegraph.co.uk/global-health/science-and-disease/bird-flu-outbreak-cows-dairy-farms-us-milk-supplies/
Should NCYT be successful with their defence and the counter claim, the cash in the back shall be in the region of £2.00 a share, however we shall have to wait and see, fingers crossed.
Wrong thread.
should have been on the 30th April one.
Good weekend to all my fellow long suffering shareholders.
The clock is ticking down.
A good reason to get down my average further next week.
Would be good if we get to £1 before we win our case, as I believe it will allow the SP to rise above £2.50.
Posted under wrong thread but I'm sure the point remains the same, pushing hard.
Https://www.linkedin.com/posts/yourgene-health_synbiobeta2024-syntheticbiology-synbio-activity-7189582584866066433-f5ZV
Are you attending #SynBioBeta2024?
Yourgene's Jacqueline Pierce - Lead Application Scientist for Ranger Technology, is presenting at a Lunch and Learn session.
🎤Topic: Ranger Technology Accelerates Genetic Engineering Workflows
🕛Date & Time: May 7 from 12:15 PM-1:00 PM
Come witness the breadth of synthetic biology solutions, hear from the industry’s leading thinkers, and make business connections you won’t find anywhere else.
📍May 6-9, 2024 in San Jose, California. Find Yourgene Health in Booth 540.
Harchris...the target price is completely wrong as a win will give them 100% straight off.
They will achieve no more if it is £5 within the 3 years
Doesn't matter what else they do they won't get any more
Tbh what they gun for means nothing...it is what they achieve..the last two years have shown that.
I do think LR will do better...certainly at playing aim game
Long term the jury is out
CS the £1.38 target isn't an incentive but the knowledge that they'll receive 950k/390k/465k shares for LR, Steve and Joanne respectively incentivises them to make as much of a success of this as possible - the difference in cash terms between £1.38 and say £5, especially for Steve and Joanne, is significant.
There's not even a chance their focus will be on just ensuring Novacyt is a £100m mcap/£1.38 a share company, they'll be gunning for many times that if they win the dispute.
WBAFC. Yes exactly. I can’t see NCYT putting an end to it at this stage. Especially as they’ve been so confident of their case all along. It’s also their reputation at stake.